Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
4,09 USD | -1,92% | -9,23% | +35,41% |
28/02 | G1 Therapeutics, Inc. Rapporteert winstresultaten voor het volledige jaar dat eindigde op 31 december 2023 | CI |
28/02 | G1 THERAPEUTICS, INC. : Wedbush herhaalt koopadvies | ZM |
Vakgebied
Aantal werknemers: 100
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Novel Small Molecule Therapeutics
56,2
%
| 31 | 61,1 % | 46 | 56,2 % | +47,89% |
License Revenue
43,8
%
| 20 | 38,9 % | 36 | 43,8 % | +81,16% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 51 | 100,0 % | 83 | 100,0 % | +60,84% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Jack Bailey
CEO | Chief Executive Officer | 59 | 12-03-20 |
John Umstead
DFI | Director of Finance/CFO | - | 01-01-18 |
Rajesh K. Malik
CTO | Chief Tech/Sci/R&D Officer | 65 | 01-07-14 |
Terry Murdock
COO | Chief Operating Officer | 64 | 03-08-17 |
Investor Relations Contact | 54 | 04-01-21 | |
Monica Thomas
HRO | Human Resources Officer | - | 22-05-23 |
Mark Avagliano
PRN | Corporate Officer/Principal | 48 | 30-07-19 |
Andrew Beelen
PRN | Corporate Officer/Principal | - | - |
Andrew Perry
PRN | Corporate Officer/Principal | 51 | 02-08-21 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Glenn Muir
BRD | Director/Board Member | 65 | 01-09-15 |
Cynthia Flowers
BRD | Director/Board Member | 64 | 07-06-18 |
Norman Sharpless
FOU | Founder | 57 | 19-05-08 |
Alicia Secor
BRD | Director/Board Member | 62 | 17-06-21 |
Garry Nicholson
CHM | Chairman | 69 | 12-09-18 |
Jack Bailey
CEO | Chief Executive Officer | 59 | 12-03-20 |
Jacks Lee
BRD | Director/Board Member | - | 27-06-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 52 226 060 | 46 103 660 ( 88,28 %) | 26 666 ( 0,0511 %) | 88,28 % |
Bedrijfsgegevens
G1 Therapeutics, Inc.
700 Park Offices Drive Suite 200
27709, Research Triangle Park
+919 213 9835
http://www.g1therapeutics.comSector
Verkoop per activiteit
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+35,41% | 218 mln. | |
-3,09% | 102 mld. | |
+1,63% | 96,07 mld. | |
-1,80% | 21,66 mld. | |
-17,55% | 20,77 mld. | |
-6,91% | 18,53 mld. | |
-42,00% | 16,91 mld. | |
-27,94% | 13,79 mld. | |
+0,12% | 13,33 mld. | |
+19,76% | 10,94 mld. |
- Beurs
- Aandelen
- Koers GTHX
- Onderneming G1 Therapeutics, Inc.